Conditions: Metastatic Cancer; Foregut Carcinoid Tumor; Gastric Adenocarcinoma; Gallbladder Adenocarcinoma; Liver Cancer; GI Cancer; GI Carcinoma; Lung Cancer
Interventions: Drug: Standard of Care Chemotherapy; Procedure: Video-Assisted Thoracic Surgery (VATS); Procedure: Lobectomy; Radiation: Consolidative Radiation; Radiation: Ablation Treatment; Procedure: Resection or Excision; Procedure: Peritonectomy; Other: Transarterial Radioembolization
Sponsor: University of Chicago
Not yet recruiting
Feeds
20859 items (20859 unread) in 74 feeds
Acinar Cell Carcinoma
(201 unread)
Acinic Cell Carcinoma
(104 unread)
Adenoid Cystic Carcinoma
(367 unread)
Adrenal Gland Cancer
(1718 unread)
Ampulla Of Vater
(213 unread)
Anal Cancer
(1799 unread)
Angiosarcoma
(359 unread)
Appendix Cancer
(450 unread)
Bile Duct Cancer
(2698 unread)
Brain and CNS
(2597 unread)
Carcinoid
(671 unread)
Endocrine/Neuroendocrine
(2404 unread)
Gall Bladder Cancer
(1146 unread)
Hemangioendothelioma
(506 unread)
Hepatoblastoma
(366 unread)
Pancreas
(416 unread)
Phyllodes
(215 unread)
PMP and Mucinous Tumors
(242 unread)
Rhabdomyosarcoma
(772 unread)
Sarcoma
(3615 unread)
Trials - Carcinoid (7 unread)
-
Study Comparing Standard of Care Therapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
Posted: June 18th, 2021, 2:00pm GMT
-
177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs
Posted: June 7th, 2021, 2:00pm GMT
Conditions: Neuroendocrine Tumors; Carcinoid Tumor; Pulmonary Carcinoid Tumor; Gastroenteropancreatic Neuroendocrine Tumor; Vipoma; Insulinoma; Gastrinoma
Intervention: Drug: 177Lu-DOTATOC
Sponsor: British Columbia Cancer Agency
Not yet recruiting -
Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19
Posted: May 6th, 2021, 2:00pm GMT
Conditions: Viral Pneumonia; COVID-19 Pneumonia; Serotonin Syndrome; Platelet Dysfunction
Intervention: Drug: Cyproheptadine Hydrochloride 4 MG
Sponsor: Ciusss de L'Est de l'Île de Montréal
Not yet recruiting -
Cyproheptadine in Severe COVID-19 : A Unblinded Randomized-controlled Trial
Posted: March 29th, 2021, 2:00pm GMT
Conditions: Viral Pneumonia; Serotonin Syndrome; Platelet Dysfunction
Intervention: Drug: Cyproheptadine Hydrochloride 4 MG
Sponsors: Ciusss de L'Est de l'Île de Montréal; Covid-19 Early Treatment Fund
Not yet recruiting -
Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor
Posted: March 22nd, 2021, 2:00pm GMT
Conditions: Locally Advanced Well Differentiated Neuroendocrine Neoplasm; Metastatic Well Differentiated Neuroendocrine Neoplasm
Interventions: Drug: Placebo Administration; Other: Questionnaire Administration; Drug: Telotristat Ethyl
Sponsor: M.D. Anderson Cancer Center
Not yet recruiting -
Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome
Posted: March 2nd, 2021, 3:00pm GMT
Conditions: Advanced Neuroendocrine Neoplasm; Carcinoid Syndrome
Interventions: Biological: Retifanlimab; Drug: Telotristat Ethyl
Sponsor: M.D. Anderson Cancer Center
Not yet recruiting -
RegisterNET - A Registry for Neuroendocrine Tumors in the USA
Posted: October 21st, 2014, 2:00pm GMT
Conditions: Neuroendocrine Tumor; Carcinoid; Neuroendocrine Carcinoma
Intervention: Device: NETest
Sponsor: Wren Laboratories LLC
Recruiting